Goserelin
Showing 51 - 75 of 340
Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Prostate Cancer
- Leuprolide acetate
- +9 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)
Active, not recruiting
- Prostate Adenocarcinoma
- +4 more
- Internal Radiation Therapy
- +7 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 1, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Breast Cancer Trial in Norway (drug, procedure, radiation)
Active, not recruiting
- Breast Cancer
- Neoadjuvant tamoxifen + goserelin (premenopausal women)
- +15 more
-
Lørenskog, Akershus, Norway
- +6 more
Aug 24, 2021
Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)
Recruiting
- Prostate Adenocarcinoma
- Leuprolide Acetate
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)
Unknown status
- Prostate Cancer
- Goserelin
- +3 more
-
Sao Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
May 14, 2021
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
RWE About QOL and Compliance of Patients With OFS in China
Not yet recruiting
- Breast Cancer
- +2 more
- 3M GnRHa
- 1M GnRHa
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 15, 2021
Prostate Adenocarcinoma, Radiation Toxicity Trial in Limassol (External beam radiation therapy, High-dose-rate brachytherapy,
Recruiting
- Prostate Adenocarcinoma
- Radiation Toxicity
- External beam radiation therapy, High-dose-rate brachytherapy
- Goserelin 10.8 mg
-
Limassol, CyprusGerman Oncology Center
Aug 6, 2021
Prostate Cancer Trial in United States (Radiation, Androgen Suppression Therapy)
Recruiting
- Prostate Cancer
- Radiation
- Androgen Suppression Therapy
-
Scottsdale, Arizona
- +3 more
Oct 24, 2021
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
Breast Cancer Trial in China (ZOLADEX 10.8 mg, ZOLADEX 3.6mg)
Withdrawn
- Breast Cancer
- ZOLADEX 10.8 mg
- ZOLADEX 3.6mg
-
Beijing, China
- +10 more
May 6, 2021
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,
Active, not recruiting
- Early-Stage Breast Carcinoma
- Estrogen Receptor Positive Tumor
- Paclitaxel
- +3 more
-
Stockholm, Sweden
- +2 more
Jul 30, 2021
Breast Cancer, Cancer of Breast, Breast Carcinoma Trial in Phoenix, Saint Louis, Buffalo (drug, biological, procedure, genetic)
Prostate Cancer Trial in Chengdu (Abiraterone acetate, Prednisolone, Goserelin)
Not yet recruiting
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Feb 3, 2021
BMD Alterations and Bone and Muscle Parameters During Menstrual
Completed
- Endometriosis
- +3 more
- Goserelin Acetate
-
Thessaloníki, Greece424 General Military Hospital
Jan 11, 2021
Dysfunctional Uterine Bleeding Trial in Kyiv (Pepti 3.6 mg)
Completed
- Dysfunctional Uterine Bleeding
- Pepti 3.6 mg
-
Kyiv, Ukraine
- +4 more
Jun 9, 2020
A Multi-centre, Prospective, Observational Study on
Completed
- Localized or Locally Advanced Prostate Cancer
-
Beijing, Beijing, China
- +22 more
Mar 5, 2020
Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)
Recruiting
- Prostate Cancer
- +4 more
- PET-directed Local Therapy using Surgery
- +10 more
-
Long Beach, California
- +15 more
Jul 29, 2022